MedPath

Suction Cervical Stabilizer Compared to Standard Tenaculum for Intrauterine Procedures

Not Applicable
Completed
Conditions
Intrauterine Device (IUD)
Abnormal Uterine Bleeding
Interventions
Device: Carevix
Device: Tenaculum
Registration Number
NCT06193590
Lead Sponsor
Indiana University
Brief Summary

To evaluate patient-reported pain, bleeding, and device efficiency along with provider satisfaction and ease of use between intrauterine procedures employing a suction cervical stabilizer (new device, FDA approved, atraumatic) or single-tooth tenaculum (standard, traumatic). This device, cleared by the FDA in 2023, was studied in Europe and showed pain reduced by up to 73% and bleeding reduced by 78% compared to the single-tooth tenaculum for intrauterine contraceptive device insertion. The investigators seek to study this device in the United States, and trial it among all intrauterine procedures.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • • Age 18 years or older

    • Speaks and reads in English
    • Able to consent on their own
    • Will undergo any intrauterine procedure using the Carevix (for exposure group) or using Tenaculum (for Control Group)
    • Cervix at least 26 mm in diameter
    • Twenty providers performing this procedure
Exclusion Criteria
  • • Vaginal bleeding of unknown origin

    • Cervix less than 26 mm in diameter
    • Nabothian cyst on anterior lip of cervix
    • Cervical myomas
    • Cervical abnormalities
    • Pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CarevixCarevixsuction cervical stabilizer utilized for intrauterine procedures
TenaculumTenaculumstandard of care cervical stabilization device
Primary Outcome Measures
NameTimeMethod
Patient-perceived painUpon cervical stabilization, and immediately after intrauterine procedure is complete

Patients will be asked to rate their pain on a 10 point Likert scale. Lower numbers represent lower pain.

Secondary Outcome Measures
NameTimeMethod
Provider-perceived satisfactionImmediately after intrauterine procedure is complete

Providers will report their perceived satisfaction indicating "Strongly Disagree, Disagree, Agree, or Strongly Agree" and open response.

Provider-perceived bleedingImmediately after intrauterine procedure is complete

Bleeding perceived by the provider during and after the procedure

Provider-perceived ease of useImmediately after intrauterine procedure is complete

Providers will report their perceived ease of use indicating "Strongly Disagree, Disagree, Agree, or Strongly Agree" and open response.

Trial Locations

Locations (1)

Indiana University Hospital

🇺🇸

Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath